E-LIB Suche - Ergebnisse für: Nicholson, Nancy S.

1

A method for determining whether hypotension caused by nove..:

Blom, Jason D. ; Yang, Po-Chang ; Nicholson, Nancy S....
Journal of Pharmacological and Toxicological Methods. 49 (2004) 1 - p. 31-37 , 2004

Link: https://doi.org/10.1016/..

2

Design, Parallel Synthesis, and Crystal Structures of Pyraz..:

Parlow, John J. ; Case, Brenda L. ; Dice, Thomas A....
Journal of Medicinal Chemistry. 46 (2003) 19 - p. 4050-4062 , 2003

Link: https://doi.org/10.1021/..

3

Administration of a small molecule tissue factor/Factor VII..:

Szalony, James A ; Suleymanov, Osman D ; Salyers, Anita K...
Thrombosis Research. 112 (2003) 3 - p. 167-174 , 2003

Link: https://doi.org/10.1016/..

4

Structure-based drug design of pyrazinone antithrombotics a..:

South, Michael S. ; Case, Brenda L. ; Wood, Rhonda S....
Bioorganic & Medicinal Chemistry Letters. 13 (2003) 14 - p. 2319-2325 , 2003

Link: https://doi.org/10.1016/..

5

Orbofiban: An orally active GPIIb/IIIa platelet receptor an..:

Nicholson, Nancy S. ; Abood, Norman A. ; Panzer‐Knodle, Susan G....
Medicinal Research Reviews. 21 (2001) 3 - p. 211-226 , 2001

Link: https://doi.org/10.1002/..

6

Protective Effect of Oral Xemilofiban in Arterial Thrombosi..:

Frederick, Leo G. ; Suleymanov, Osman D. ; Szalony, James A....
Circulation. 98 (1998) 8 - p. 813-820 , 1998

Link: https://doi.org/10.1161/..

7

Assessment of platelet function assays:

Nicholson, Nancy S. ; Panzer-Knodle, Susan G. ; Haas, Neal F....
American Heart Journal. 135 (1998) 5 - p. S170-S178 , 1998

Link: https://doi.org/10.1016/..

8

The Protective Dose of the Potent GPIIb/IIIa Antagonist SC-..:

Frederick, Leo G. ; Suleymanov, Osman D. ; King, Lucy W....
Circulation. 93 (1996) 1 - p. 129-134 , 1996

Link: https://doi.org/10.1161/..

9

SC-54684A: An Orally Active Inhibitor of Platelet Aggregati..:

Nicholson, Nancy S. ; Panzer-Knodle, Susan G. ; Salyers, Anita K....
Circulation. 91 (1995) 2 - p. 403-410 , 1995

Link: https://doi.org/10.1161/..

10

Extended Inhibition of Platelet Aggregation With the Orally..:

Szalony, James A. ; Haas, Neal F. ; Salyers, Anita K....
Circulation. 91 (1995) 2 - p. 411-416 , 1995

Link: https://doi.org/10.1161/..

11

A novel series of orally active antiplatelet agents:

Zablocki, Jeffery A. ; Tjoeng, Foe S. ; Bovy, Philippe R....
Bioorganic & Medicinal Chemistry. 3 (1995) 5 - p. 539-551 , 1995

Link: https://doi.org/10.1016/..

12

SC-49992-A potent and specific inhibitor of platelet aggreg..:

Nicholson, Nancy S. ; Panzer-Knodle, Susan G. ; King, Lucy W....
Thrombosis Research. 74 (1994) 5 - p. 523-535 , 1994

Link: https://doi.org/10.1016/..

13

Species variation in the effect of glycoprotein IIb/IIIa an..:

Panzer-Knodle, Susan ; Taite, Beatrice B. ; Mehrotra, Devan V...
Journal of Pharmacological and Toxicological Methods. 30 (1993) 1 - p. 47-53 , 1993

Link: https://doi.org/10.1016/..

14

A radioreceptor binding assay for measurement of platelet-a..:

Paulson, Susan K. ; Nicholson, Nancy S.
Journal of Immunological Methods. 110 (1988) 2 - p. 209-215 , 1988

Link: https://doi.org/10.1016/..

15

NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant In..:

Drilon, Alexander ; Horan, Joshua C. ; Tangpeerachaikul, Anupong...
Cancer Discovery. 13 (2022) 3 - p. 598-615 , 2022

Link: https://doi.org/10.1158/..